CNA3103

LGR5-targeted autologous CAR-T cells · Carina Biotech Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CNA3103, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer [Phase 1, Phase 2]

See pricing